Full Access
Reversibility of Tardive Dyskinesia
Hitoshi Itoh M.D.,
Gohei Yagi M.D.,
Hitoshi Itoh M.D.
Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo
Search for more papers by this authorGohei Yagi M.D.
Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo
Search for more papers by this authorHitoshi Itoh M.D.,
Gohei Yagi M.D.,
Hitoshi Itoh M.D.
Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo
Search for more papers by this authorGohei Yagi M.D.
Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo
Search for more papers by this author
References
- 1 Abuzzahab, Sr. F. S. (organized): Symposium on tardive dyskinesia, Minneapolis , U.S.A. , July Ist, 1976.
- 2 Allen, R. E. and Stimmel, G. L.: Neurolep-tic dosage, duration, and tardive dyskinesia, Dis Nerv Syst, 38: 385–387, 1977.
- 3 Ayd, F.: Treatment of persistent dyskinesia, International Drug Therapy Newsletter, VII, 3: 9–11, March, 1972.
- 4 Ayd, F.: On the reversibility of tardive dyskinesia, International Drug Therapy Newsletter, II, 9: 35–36, Nov., 1976.
- 5 Chien, C. P., Chung, K., Ross-Towsend, A. et al.: The measurement of tardive dyskinesia by piezoelectric recording and clinical rating scales, Xth Collegium Internationale Neuropsychopharmacologicum, Quebec , Canada , July 4–9, 1976.
- 6 Crane, G. E.: Tardive dyskinesia: A review: Neuropsychopharmacology, Proceedings of the IX Congress of the Collegium Internationale Neuropsychopharmacologicum Paris, 7–12 July, 1974, 346–354, Excerpta Medica Foundation, Amsterdam , 1975.
- 7 Curran, J. P.: Tardive dyskinesia: Side effect or not Amer J Psycniat., 130: 406–410, 1973.
- 8 Degkwitz, R. and Wenzel, W.: Persistent extrapyramidal side effects after long-term application of neuroleptics, In: Brill, H.: Neuropsychopharmacology, V: 608–615, 1967.
- 9 Donlon, P. T. and Stenson, R. L.: Neuro-leptic induced extrapyramidal symptoms, Dis Nerv Syst, 37: 629–635, 1976.
- 10 Edwards, H.: The significance of brain damage in persistent oral dyskinesia, Brit J Psychiat., 118: 271–275, 1970.
- 11 Fann, W. E., Lake, C. R. and Richman, B. W.: Drug induced parkinsonism: A reevaluation, Dis Nerv Syst, 36: 91–93, 1975.
- 12 Faurbye, A., Rasch, P.-J., Bender Petersen, P., Brandborg, G. and Pakkenberg, H.: Neurological symptoms in pharmacotherapy of psychoses, Acta Psychiat Scand., 40: 10–27, 1964.
- 13 Gerlach, J. and Thorsen, K.: The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment, Int Pharmacopsychiat., 11: 1–7, 1976.
- 14 Haddenbrock, S.: Zur Wirkungsweise und zur Frage zentralorganischer Spatschaden der neuroleptischen Dauerbehandlung, Nervenazt, 37: 199–203, 1966.
- 15 Itoh, H., Miura, S., Yagi, G., Tsuji, E., Ogita, K., Sakurai, S., Tanaka, N., Nakamura, S. and Kamishima, K.: Irreversible dyskinesia associated with long-term usage of psychotropic drugs, Annual Rep Pharmacol Res Found., 3: 190–195, 1971.
- 16 Itoh, H., Yagi, G., Ogita, K., Ohtsuka, N. and Miura, S.: On the reversibility of tardive dyskinesia—A follow-up study and a film presentation, Xth Collegium Internationale Neuro-psychopharmacologicum, Quebec , July 4–9, 1976.
- 17 Itoh, H., Yagi, G., Ogita, K. and Miura, S.: Irreversible dyskinesia after long-term psychopharmacotherapy, Nippon-ijishinpoh, 2582: 29–34, 1973.
- 18 Kazamatsuri, H., Chien, Ch.-P. and Cole, J. O.: Long-term treatment of tardive dyskinesia with haloperidol and tetrabena-zine, Amer J Psychiat., 130: 479–482, 1973.
- 19 Klawans, H. L.: The pharmacology of tardive dyskinesias, Amer J Psychiat, 130: 82–86, 1973.
- 20 Moline, R. A.: Atypical tardive dyskinesia, Amer J Psychiat., 132: 534–535, 1975.
- 21 Otani, Y., Takase, K., So, Y., Itoh, I. and Nishibori, K.: Tardive dyskinesia. Psychiat Neurol Jap., 76: 310–311, 1974.
- 22 Quitkin, F., Rifkin, A., Gochfeld, L. and Klein, D.: Tardive dyskinesia: Are first signs reversible Amer I Psychiat., 134: 84–87, 1977.
- 23 Roxburgh, P. A.: Treatment of persistent phenothiazine-induced oral dyskinesia, Brit J Psychiat., 116: 277–280, 1970.
- 24 Tarsy, D. and Baldessarini, R. J.: The tardive dyskinesia syndrome, In: Clinical Neuropharmacology Vol. 1, Klawans, H. L., 29–61, 1976, Raven Press, New York .
- 25 Turunen, S. and Achté, K. A.: The buccolinguo-masticatory syndrome as a side-effect of neuroleptics therapy, Psychiat Fenn 1972, 365–371.
- 26 Uhrbrand, L. and Faurbye, A.: Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine, and electroconvulsive therapy, Psychopharmacologia, 1: 408–418, 1960.
- 27
Villeneuve, A. and
Boszörmenyi, Z.: Treatment of drug-induced dyskinesias, The Lancet, Feb. 14: 353–354, 1970.
10.1016/S0140-6736(70)90724-5 Google Scholar
- 28 Yagi, G., Ogita, K., Ohtsuka, N., Itoh, H. and Miura, S.: Persistent dyskinesia after long-term treatment with neuroleptics in Japan. Its present status and clinical problems, Keio J Med., 25: 27–35, 1976.
